“Best Practice in Personalised Medicine” Recognition 2023 – now open for applications

The International Consortium for Personalised Medicine, ICPerMed, launched on February 22, 2023, its sixth Best Practice Recognition. The objective of the ICPerMed Recognition 2023 is to honour, encourage, promote and disseminate outstanding examples of implementation through research in Personalised Medicine.

The deadline for the submission of the proposals is April 30th, 2023.

First authors (applicants from any countries worldwide) of candidate proposals published and/or developed between January 1st, 2021 and December 31st, 2022 are eligible to apply.

The selected authors will be invited to the next ICPerMed Workshop taking place in November 2023 and will be given the opportunity to present their results during a plenary session to stakeholders interested in the area of PM.

Further details on the ICPerMed “Best Practice in Personalised Medicine” Recognition 2023 and on the application process are available here:

Call for Applications

Application Form

For further questions please contact:

Italian Ministry of Health: healthresearch(at) 

Chiara Ciccarelli : c.ciccarelli(at) 

Simona Bifolchi : s.bifolchi(at) / Phone: +39 0659946514


Infobox ICPerMed

ICPerMed was established in November 2016 and comprises over 40 European and international members representing research and health ministries as well as funding agencies, including the European Commission as observer. The aim of ICPerMed is to boost personalised medicine by an enhanced coordination and alignment of research activities.

The French National Research Agency (ANR) is implicated in ICPerMed as well as in the ICPerMed Coordination and Support Action (ICPerMed Secretariat; CSA), ERA PerMed, the ERA Net on Personalised Medicine and EU-Africa PerMed.

More information about the different programmes around Personalised Medicine

Last updated on 22 March 2023
Sign up for the latest news:
Subscribe to our newsletter